IL-23 and Sjogren's syndrome Archives

Abstract Number: 6 • ACR/ARHP Annual Meeting 2015
The Novel Role of Corticotropin-Releasing Hormone and Urocortin1 on Sjogren’s Syndrome
Yuichi Yokoyama¹, Kiyoshi Matsui², Sachie Kitano², Tetsuya Furukawa³, Masahiro Sekiguchi², Naoto Azuma², Masayasu Kitano², Shinichiro Tsunoda², Tsuyoshi Iwasaki⁴ and Hajime Sano², ¹Division of Rheumatology, Department of internal medicine, Hyogo College of Medicine, Nishinomiya, Japan, ²Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan, ³Division ofRheumatology Department of internal medicine, Hyogo College of Medicine, Nishinomiya, Japan, ⁴Department of Pharmacy, Hyogo University of Health Sciences, Kobe, Japan
Background/Purpose: Corticotropin releasing hormone (CRH) is the principal regulator of hypothalamus pituitary adrenal (HPA) axis. CRH and urocortin1 (UCN1) are member of the CRH family.…

Abstracts tagged "IL-23 and Sjogren’s syndrome"